MDT

87.11

-0.93%↓

A

115.09

-0.3%↓

VEEV

151.46

-3.57%↓

HQY

78.12

-6.83%↓

TLRY

6.58

-1.94%↓

MDT

87.11

-0.93%↓

A

115.09

-0.3%↓

VEEV

151.46

-3.57%↓

HQY

78.12

-6.83%↓

TLRY

6.58

-1.94%↓

MDT

87.11

-0.93%↓

A

115.09

-0.3%↓

VEEV

151.46

-3.57%↓

HQY

78.12

-6.83%↓

TLRY

6.58

-1.94%↓

MDT

87.11

-0.93%↓

A

115.09

-0.3%↓

VEEV

151.46

-3.57%↓

HQY

78.12

-6.83%↓

TLRY

6.58

-1.94%↓

MDT

87.11

-0.93%↓

A

115.09

-0.3%↓

VEEV

151.46

-3.57%↓

HQY

78.12

-6.83%↓

TLRY

6.58

-1.94%↓

Search

Quidel Corp

Fermé

13.88 -2.05

Résumé

Variation du prix de l'action

24h

Actuel

Min

13.88

Max

14.13

Chiffres clés

By Trading Economics

Revenu

602M

-131M

Ventes

24M

724M

Marge bénéficiaire

-18.062

Employés

6,500

Recommandations

By TipRanks

Recommandations

Neutre

Prévisions sur 12 Mois

+98.56% upside

Dividendes

By Dow Jones

Prochains Résultats

6 mai 2026

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

-193M

1B

Ouverture précédente

15.93

Clôture précédente

13.88

Quidel Corp Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

10 avr. 2026, 17:04 UTC

Principaux Mouvements du Marché

FDA Rejects Replimune's Melanoma Drug for a Second Time

11 avr. 2026, 09:30 UTC

Résultats

After the Great EV Slowdown, High Gas Prices Are Tempting Americans Back -- WSJ

11 avr. 2026, 08:20 UTC

Market Talk

Energy & Utilities Roundup: Market Talk

11 avr. 2026, 08:20 UTC

Market Talk

Health Care Roundup: Market Talk

11 avr. 2026, 08:20 UTC

Market Talk
Principaux Événements d'Actualité

Basic Materials Roundup: Market Talk

11 avr. 2026, 00:00 UTC

Résultats
Acquisitions, Fusions, Rachats

Big Yachts, Big Bucks -- Barrons.com

10 avr. 2026, 21:55 UTC

Acquisitions, Fusions, Rachats

Paramount Warrants Are an Underappreciated Aspect of Warner Bros. Deal -- Barrons.com

10 avr. 2026, 21:01 UTC

Résultats

Cango Inc.: Files Annual Report on Form 20-F With SEC

10 avr. 2026, 20:50 UTC

Market Talk

Energy & Utilities Roundup: Market Talk

10 avr. 2026, 20:50 UTC

Market Talk
Principaux Événements d'Actualité

Basic Materials Roundup: Market Talk

10 avr. 2026, 20:50 UTC

Market Talk

Health Care Roundup: Market Talk

10 avr. 2026, 20:31 UTC

Market Talk

Convenience Store Traffic Slows as Gas Prices Rise -- Market Talk

10 avr. 2026, 20:10 UTC

Acquisitions, Fusions, Rachats

This Women's Health Company Is Drawing Takeover Interest. The Stock Is Soaring. -- Barrons.com

10 avr. 2026, 19:15 UTC

Market Talk

Global Energy Roundup: Market Talk

10 avr. 2026, 19:15 UTC

Market Talk

Oil Futures Settle Lower With Focus on U.S.-Iran Talks -- Market Talk

10 avr. 2026, 19:08 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

10 avr. 2026, 19:08 UTC

Market Talk

U.S. Natural Gas Futures End Week Lower -- Market Talk

10 avr. 2026, 18:38 UTC

Market Talk

Canada's Job Market Showing Soft Demand, Structural Decline in Supply -- Market Talk

10 avr. 2026, 18:25 UTC

Market Talk
Principaux Événements d'Actualité

Precious Metals Finish With Weekly Gains -- Market Talk

10 avr. 2026, 18:05 UTC

Market Talk

Rising Commodity Prices Seen Carrying More Weight Than Jobs Data for Bank of Canada Watchers -- Market Talk

10 avr. 2026, 17:31 UTC

Market Talk
Principaux Événements d'Actualité

U.S. Oil Rig Count Unchanged This Week At 411 -- Market Talk

10 avr. 2026, 17:26 UTC

Résultats

Big Banks' Profits Set to Rise Even as 'Wall of Worry' Looms -- Barrons.com

10 avr. 2026, 17:10 UTC

Market Talk

White House Defense of Stablecoin Yields Is Welcome Move, Grayscale Says -- Market Talk

10 avr. 2026, 17:00 UTC

Principaux Événements d'Actualité

Construction Business Taking a Hit From Iran Conflict -- WSJ

10 avr. 2026, 16:20 UTC

Market Talk

Health Care Roundup: Market Talk

10 avr. 2026, 16:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

10 avr. 2026, 16:12 UTC

Résultats

Partners Group CEO: Group Well Positioned to Navigate Current Complex Environment

10 avr. 2026, 16:11 UTC

Résultats

Partners Group: Traditional Programs Contributed $3.3B

10 avr. 2026, 16:10 UTC

Résultats

Partners Group: $5B of New Commitments Came From Bespoke Solutions

10 avr. 2026, 16:10 UTC

Résultats

Partners Group: That Is Across All Private Markets Asset Classes and Client Strategies

Comparaison

Variation de prix

Quidel Corp prévision

Objectif de Prix

By TipRanks

98.56% hausse

Prévisions sur 12 Mois

Moyen 27.5 USD  98.56%

Haut 38 USD

Bas 17 USD

Basé sur 5 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Neutre

5 ratings

1

Achat

3

Maintien

1

Vente

Éléments financiers

Frais Généraux et Administratifs

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

Bénéfice d'exploitation

$

À Propos Quidel Corp

QuidelOrtho Corporation provides diagnostic testing solutions. The company operates through Labs, Transfusion Medicine, Point-of-Care, and Molecular Diagnostics business units. The Labs business unit provides clinical chemistry laboratory instruments and tests that measure target chemicals in bodily fluids for the evaluation of health and the clinical management of patients; immunoassay laboratory instruments and tests, which measure proteins as they act as antigens in the spread of disease, antibodies in the immune response spurred by disease, or markers of proper organ function and health; testing products to detect and monitor disease progression across a spectrum of therapeutic areas; and specialized diagnostic solutions. The Transfusion Medicine business unit offers immunohematology instruments and tests used for blood typing to ensure patient-donor compatibility in blood transfusions; and donor screening instruments and tests used for blood and plasma screening for infectious diseases. The Point-of-Care business unit provides instruments and tests to provide rapid results across a continuum of point-of-care settings. The Molecular Diagnostics business unit offers polymerase chain reaction thermocyclers; amplification systems; and sample-to-result molecular instruments and tests for syndromic infectious disease diagnostics. The company sells its products directly to end users through a direct sales force; and through a network of distributors for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, urgent care clinics, universities, retail clinics, pharmacies, wellness screening centers, blood banks, and donor centers, as well as for individual, non-professional, and over-the-counter use. It operates in North America, Europe, the Middle East, Africa, China, and internationally. The company was incorporated in 1979 and is headquartered in San Diego, California.
help-icon Live chat